Gene Security Network changes name to Natera

Monday, January 9, 2012 01:57 PM

Gene Security Network, a preconception and prenatal genetic testing company, announced on Jan.6 its name change to Natera.

The name change accompanies reaching $20 million in funds raised, which the company will use to continue development and commercialization of its noninvasive prenatal diagnostic for Down syndrome and other genetic conditions.

"For me, our new name evokes birth, nature and earth, and reflects our mission to help couples around the world manage pregnancies and reduce the risk of genetic disease," said Matthew Rabinowitz, CEO of Natera.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs